Peter A Forsberg

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Topics

Multiple Myeloma

Transcription Factor

Newly Diagnosed

Stem Cell Transplantation

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

American journal of hematology

Cancer research communications

Clinical case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Lorraine N Davis, Zachary J Walker, Lauren T Reiman, Sarah E Parzych, Brett M Stevens, Craig T Jordan, Peter A Forsberg, Daniel W Sherbenou
MYC Inhibition Potentiates CD8+ T Cells Against Multiple Myeloma and Overcomes Immunomodulatory Drug Resistance. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Lorraine N Davis, Zachary J Walker, Lauren T Reiman, Sarah E Parzych, Brett M Stevens, Craig T Jordan, Peter A Forsberg, Daniel W Sherbenou
MYC Inhibition Potentiates CD8+ T Cells Against Multiple Myeloma and Overcomes Immunomodulatory Drug Resistance. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Alana L Keller, Lauren T Reiman, Olivia Perez de Acha, Sarah E Parzych, Peter A Forsberg, Peter S Kim, Kamlesh Bisht, Hongfang Wang, Helgi Van de Velde, Daniel W Sherbenou
Ex Vivo Efficacy of SAR442257 anti-CD38 Trispecific T Cell Engager in Multiple Myeloma Relapsed After Daratumumab and BCMA Targeted Therapies. Cancer research communications (2024)
Lorraine N Davis, Zachary J Walker, Lauren T Reiman, Sarah E Parzych, Brett M Stevens, Craig T Jordan, Peter A Forsberg, Daniel W Sherbenou
MYC Inhibition Potentiates CD8+ T Cells Against Multiple Myeloma and Overcomes Immunomodulatory Drug Resistance. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Lorraine N Davis, Zachary J Walker, Lauren T Reiman, Sarah E Parzych, Brett M Stevens, Craig T Jordan, Peter A Forsberg, Daniel W Sherbenou
MYC Inhibition Potentiates CD8+ T Cells Against Multiple Myeloma and Overcomes Immunomodulatory Drug Resistance. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Alana L Keller, Lauren T Reiman, Olivia Perez de Acha, Sarah E Parzych, Peter A Forsberg, Peter S Kim, Kamlesh Bisht, Hongfang Wang, Helgi Van de Velde, Daniel W Sherbenou
Ex Vivo Efficacy of SAR442257 Anti-CD38 Trispecific T-cell Engager in Multiple Myeloma Relapsed After Daratumumab and BCMA-targeted Therapies. Cancer research communications 4 (3) (2024)
Stephanie Lakritz, Peter A Forsberg, Daniel W Sherbenou, Tomer M Mark
Lenalidomide-induced autoimmune enteropathy complicating treatment of multiple myeloma with concurrent systemic mastocytosis. Clinical case reports 10 (9) (2022)
Peter A Forsberg, Adriana C Rossi, Angelique Boyer, Roger N Pearse, Karen A Pekle, David Jayabalan, Stephanie Lakritz, Kari Flicker, Drew Ribadeneyra, Brielle Liotta, Scott Ely, Leora Boussi, John N Allan, Morton Coleman, Ruben Niesvizky, Tomer M Mark
Carfilzomib and dexamethasone induction with lenalidomide, clarithromycin and dexamethasone consolidation and lenalidomide maintenance for newly diagnosed multiple myeloma. American journal of hematology 96 (12) (2021)
Peter A Forsberg, Adriana C Rossi, Angelique Boyer, Linda Tegnestam, Roger N Pearse, Arthur Perry, Karen A Pekle, David Jayabalan, Scott Ely, Leora Boussi, Daniel W Sherbenou, Colt Williams, John N Allan, Morton Coleman, Ruben Niesvizky, Tomer M Mark
Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma. American journal of hematology 94 (5) (2019)